ETF · Xtrackers
SDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF
ISIN IE00036F4K40London Stock Exchange: SDG3Deutsche Bank AG
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Latest close
LSE£31.67
on
- Ongoing charge
- 0.35% a year
- Fund size
- £23.0m
As of , at least 15 min delayed
At a glance
As of 20/11/2026, SDG3 (Xtrackers MSCI Global SDG 3 Good Health UCITS ETF, ISIN IE00036F4K40) closed at £31.67 on the London Stock Exchange. Its ongoing charge is 0.35% a year (about £35 on £10,000). Over the three years to 20/11/2026 its total return was +33.5%, or +20.2% after UK CPIH inflation.
Past returns
- 1 year to 20/11/2026
- +11.5%
- +7.6% after inflation (UK CPIH)
- 3 years to 20/11/2026
- +33.5%
- +20.2% after inflation (UK CPIH)
Returns: as reported (delayed data) and worked out from recorded daily closes. Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF in pounds (price, with income reinvested in the fund): 2024 +6.1%, 2025 +4.5%; 2026 to 20/11/2026 +13.7%. Returns of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +8.6%; to 30/09/2025: −1.4%; to 30/09/2024: +11.7%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +13.7% | +9.6% | |
| to | +4.5% | +1.0% | |
| to | +6.1% | +2.5% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +8.6% | +4.7% |
| from | −1.4% | −5.2% |
| from | +11.7% | +8.9% |
As of , inflation: UK CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
15.0%over 3 years
| 1 year | 17.2% |
|---|---|
| 3 years | 15.0% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since February 2023
- −15.4%
- From to
- Lowest 12-month return
- −10.3%
- 12 months to
- Highest 12-month return
- +19.2%
- 12 months to
- Below its highest weekly close since February 2023
- 2.4%
- High of , latest
In words: Volatility of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF in pounds, annualised from weekly returns to 20/11/2026: 17.2% over 1 year, 15.0% over 3 years. Largest fall in the price of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF since February 2023, in pounds: −15.4% from 30/08/2024 to 11/04/2025. The lowest 12-month return of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF in pounds (price, with income reinvested in the fund) since February 2023 was −10.3% (12 months to 08/08/2025); the highest was +19.2% (12 months to 25/09/2026). On 20/11/2026 the price of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF was 2.4% below its highest weekly close since February 2023 (13/11/2026), in pounds.
As of , price, with income reinvested in the fund
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.35%
- a year
- On £10,000
- £35
- a year, roughly
- Over five years
- £174
- of £10,000, before growth
- 14 charge less
- 3 the same
- 11 charge more
Ongoing charge of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 0.35% a year. Compared on 21/11/2026, 11 of the 28 other healthcare funds charge more, 3 the same and 14 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
As of
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2023.
It tracks the MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index — large and medium-sized companies across developed and emerging markets.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.35% a year — about £35 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- SDG3
- ISIN
- IE00036F4K40
- Also listed as
- XDG3 (London Stock Exchange, US dollars)
- Provider
- Xtrackers
- Tracks
- MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Ongoing charge
- 0.35% a year · about £35 on £10,000
- Fund size
- £23.0m
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Over the last year, the closing price went from £28.29 on 21/11/2025 to £31.67 on 20/11/2026 (+11.9%). The lowest close shown was £25.04 on 08/05/2026 and the highest £32.44 on 13/11/2026.
One close a week. Before 23/10/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded.
As of , at least 15 min delayed
Five years of prices, and after inflation
197 weekly closes, from 17/02/2023 to 20/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
- Holdings
- 119
- 130 reported in all
- Ten largest
- 45.0%
- of the whole fund
- Effective number of holdings
- 33
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 5.0%
- Thermo Fisher Scientific
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Thermo Fisher ScientificTMOHealth CareUnited States | 4.95% |
| 2 | Eli LillyLLYHealth CareUnited States | 4.84% |
| 3 | AbbVieABBVHealth CareUnited States | 4.80% |
| 4 | Gilead SciencesGILDHealth CareUnited States | 4.77% |
| 5 | DanaherDHRHealth CareUnited States | 4.76% |
| 6 | AmgenAMGNHealth CareUnited States | 4.58% |
| 7 | Johnson & JohnsonJNJHealth CareUnited States | 4.50% |
| 8 | MerckMRKHealth CareUnited States | 4.19% |
| 9 | Vertex PharmaceuticalsVRTXHealth CareUnited States | 3.94% |
| 10 | AstraZenecaAZNHealth CareUnited Kingdom | 3.68% |
As of , holdings as published
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By sector
- Health Care98.0%
- Consumer Staples1.3%
- Industrials0.5%
- Other funds0.1%
- Not classified0.2%
By country
- United States78.5%
- United Kingdom5.7%
- Denmark3.7%
- France2.5%
- Japan2.4%
- Netherlands2.4%
- Australia1.4%
- Switzerland1.1%
- Other countries2.1%
- Not classified0.1%
By type of asset
- Equity99.8%
- Cash and money market0.3%
See the full portfolio
Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 100 largest and what changed since .
More of the portfolio
The fund publishes 130 holdings; the ten largest make up 45.0% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1 and 3 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 145 rolling 12-month returns since February 2023, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since February 2023, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Rank among similar funds
Rank by total return over 1 year among up to 11 healthcare funds investing globally, not currency-hedged, highest first.
ProMoves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core MSCI World UCITS ETF, over the three years to 20/11/2026 (154 weeks).
Pro
Pro — currently by invitation
Pro includes the rank among similar funds and moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of SDG3?
The ongoing charge of SDG3 is 0.35% a year — about £35 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 0.35% a year. Compared on 21/11/2026, 11 of the 28 other healthcare funds charge more, 3 the same and 14 less (share classes counted once).
What does SDG3 track?
SDG3 tracks the MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index — large and medium-sized companies across developed and emerging markets.
Is SDG3 accumulating or distributing?
SDG3 is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of SDG3?
The ISIN of SDG3 is IE00036F4K40. An ISIN identifies one exact share class of a fund; SDG3 is its ticker on the London Stock Exchange. The same share class is also listed as XDG3 (London Stock Exchange, US dollars).
What does SDG3 hold?
As of 15/11/2026, SDG3 holds 130 positions, according to its published holdings. The largest is Thermo Fisher Scientific at 4.95% of the fund; the ten largest make up 45.0%. Its ten largest holdings are Thermo Fisher Scientific (4.95%), Eli Lilly (4.84%), AbbVie (4.80%), Gilead Sciences (4.77%), Danaher (4.76%), Amgen (4.58%), Johnson & Johnson (4.50%), Merck (4.19%), Vertex Pharmaceuticals (3.94%) and AstraZeneca (3.68%).
What were SDG3’s returns in each of the last five years?
Calendar-year returns of SDG3 in pounds (price, with income reinvested in the fund): 2024 +6.1%, 2025 +4.5%; 2026 to 20/11/2026 +13.7%. Past performance is not a guide to future returns.
How has SDG3 done after inflation?
Over the three years to 20/11/2026 SDG3’s total return was +33.5%, or +20.2% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.2bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £994m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £847m
- ESIHiShares MSCI Europe Health Care Sector UCITS ETF Accum EUR0.18% a year · £792m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £779m
Fund documents and methods
- Fund documents
- Fund page at Xtrackers (DWS) (links checked )
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.